Medicare Enrolled
Dr. Laura Nadeau, M.D.
Hematology & Oncology · Royal Oak, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nadeau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nadeau?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nadeau
Dr. Laura Nadeau is a hematology & oncology specialist in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nadeau performed 76,247 Medicare services across 3,872 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nadeau received a total of $10,701 from 88 pharmaceutical and/or device companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nadeau is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in MI
$10,701 industry payments
Medicare Practice Summary
Medicare Utilization ↗76,247
Medicare services
Top 7% in MI for hematology & oncology
3,872
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,812 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
26,520 | $0 | $2 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
23,700 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 8,220 | $18 | $43 |
| Pembrolizumab injection (Keytruda) | 6,000 | $43 | $105 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,460 | $6 | $17 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,270 | $8 | $11 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,231 | $8 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 720 | $1 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
686 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
590 | $6 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
456 | $11 | $37 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $70 | $186 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
370 | $94 | $265 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
352 | $5 | $10 |
| Liver function blood test panel | 351 | $8 | $17 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
350 | $6 | $13 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
350 | $4 | $10 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
349 | $8 | $17 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
312 | $138 | $372 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
306 | $7 | $14 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
277 | $12 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
239 | $64 | $146 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
234 | $102 | $276 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
184 | $1 | $4 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
145 | $6 | $20 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
116 | $1 | $2 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
84 | $140 | $397 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
82 | $58 | $153 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
79 | $2 | $6 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
76 | $1 | $3 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
68 | $29 | $79 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
65 | $22 | $59 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
61 | $49 | $136 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
60 | $25 | $95 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
56 | $16 | $48 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
56 | $22 | $61 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
56 | $27 | $67 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
51 | $51 | $134 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
50 | $10 | $40 |
| New patient office visit, complex (60-74 min) | 34 | $164 | $453 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
31 | $72 | $135 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
31 | $8 | $9 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
26 | $1 | $3 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
25 | $66 | $205 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
19 | $40 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.5% high complexity
56.4% medium
8.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,701
Total received (2018-2024)
Avg $1,529/year across 7 years
Top 17% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
587
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,483 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$117 (1.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,237
2023
$2,102
2022
$1,781
2021
$455
2020
$352
2019
$1,747
2018
$2,025
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$353
Genentech USA, Inc.
$256
Janssen Biotech, Inc.
$247
Daiichi Sankyo Inc.
$161
Gilead Sciences, Inc.
$130
Merck Sharp & Dohme LLC
$125
Eisai Inc.
$83
TerSera Therapeutics LLC
$74
GENZYME CORPORATION
$68
ABBVIE INC.
$63
Lilly USA, LLC
$62
PFIZER INC.
$60
E.R. Squibb & Sons, L.L.C.
$52
Regeneron Healthcare Solutions, Inc.
$42
EMD Serono, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$33
Bayer Healthcare Pharmaceuticals Inc.
$32
Genmab U.S., Inc.
$24
Organon Llc
$23
BeiGene USA, Inc.
$23
TAIHO ONCOLOGY, INC.
$22
Tempus AI, Inc
$22
Ipsen Biopharmaceuticals, Inc
$21
AIMMUNE THERAPEUTICS, INC.
$20
PUMA BIOTECHNOLOGY, INC.
$18
Pharmacosmos Therapeutics Inc.
$18
Incyte Corporation
$18
Stemline Therapeutics Inc.
$18
AstraZeneca Pharmaceuticals LP
$18
Kyowa Kirin, Inc.
$18
SOBI, INC
$17
Myriad Genetic Laboratories, Inc.
$16
Agios Pharmaceuticals, Inc.
$16
Mirati Therapeutics, Inc.
$15
Celgene Corporation
$15
Aveo Pharmaceuticals, Inc.
$13
Top 3 companies account for 38.3% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$1,023
AstraZeneca Pharmaceuticals LP
$902
Novartis Pharmaceuticals Corporation
$889
Amgen Inc.
$554
Lilly USA, LLC
$484
Janssen Biotech, Inc.
$466
Gilead Sciences, Inc.
$438
PFIZER INC.
$325
Merck Sharp & Dohme Corporation
$305
Merck Sharp & Dohme LLC
$267
Exelixis Inc.
$259
E.R. Squibb & Sons, L.L.C.
$234
Eisai Inc.
$230
GENZYME CORPORATION
$226
Daiichi Sankyo Inc.
$195
TerSera Therapeutics LLC
$195
EMD Serono, Inc.
$191
Seagen Inc.
$176
Regeneron Healthcare Solutions, Inc.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$157
Mirati Therapeutics, Inc.
$150
Celgene Corporation
$141
EISAI INC.
$134
Focal Therapeutics, Inc.
$129
Janssen Pharmaceuticals, Inc
$124
GlaxoSmithKline, LLC.
$102
Incyte Corporation
$102
COMSORT, Inc
$100
G1 Therapeutics, Inc.
$98
Puma Biotechnology, Inc.
$91
BeiGene USA, Inc.
$89
Kite Pharma, Inc.
$86
SANOFI-AVENTIS U.S. LLC
$84
Bayer Healthcare Pharmaceuticals Inc.
$79
ABBVIE INC.
$63
SERVIER PHARMACEUTICALS LLC
$63
AMAG Pharmaceuticals, Inc.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Medtronic, Inc.
$51
Rigel Pharmaceuticals, Inc.
$50
Stemline Therapeutics Inc.
$49
Alexion Pharmaceuticals, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$45
AVEO Pharmaceuticals, Inc.
$44
Kyowa Kirin, Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$39
AbbVie, Inc.
$38
Endomagnetics Ltd
$38
PharmaEssentia USA Corporation
$37
SOBI, INC
$34
Servier Pharmaceuticals LLC
$32
Secura Bio, Inc.
$31
Helsinn Therapeutics (U.S.), Inc.
$30
Taiho Oncology, Inc.
$27
ARRAY BIOPHARMA INC
$27
Aveo Pharmaceuticals, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$26
Sobi, Inc
$26
Shire North American Group Inc
$25
INSYS Therapeutics Inc
$25
Genmab U.S., Inc.
$24
Astellas Pharma US Inc
$24
Organon Llc
$23
Verastem, Inc.
$22
TAIHO ONCOLOGY, INC.
$22
Tempus AI, Inc
$22
Ipsen Biopharmaceuticals, Inc
$21
Pharmacyclics LLC, An AbbVie Company
$20
AIMMUNE THERAPEUTICS, INC.
$20
Pharmacosmos Therapeutics Inc.
$18
Dova Pharmaceuticals
$18
Midatech Pharma US Inc
$17
Advanced Accelerator Applications
$17
JAZZ PHARMACEUTICALS INC.
$17
Myriad Genetic Laboratories, Inc.
$16
Agios Pharmaceuticals, Inc.
$16
Deciphera Pharmaceuticals Inc.
$16
TESARO, Inc.
$16
Array BioPharma Inc.
$16
Karyopharm Therapeutics Inc.
$15
Sumitomo Pharma America, Inc.
$14
MorphoSys, US Inc.
$13
Seattle Genetics, Inc.
$13
Fortovia Therapeutics, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Clovis Oncology, Inc.
$12
Foundation Medicine, Inc.
$12
Heron Therapeutics, Inc.
$10
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALTUVIIIO · ALUNBRIG · Abraxane · Alecensa · Aranesp · Avastin · BALVERSA · BAVENCIO · BENDEKA · BESREMI · BLENREP · BRAFTOVI · BRUKINSA · Balversa · Bavencio · BioZorb · Blincyto · Braftovi · CABLIVI · CABOMETYX · CARVYKTI · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Cometriq · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ENJAYMO · EXKIVITY · Enhertu · Epkinly · Erleada · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gazyva · Gelclair · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INVOKANA · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIGASURE · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · Magseed · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSTATE CANCER - DISEASE · PYRUKYND · Perjeta · Phesgo · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAFINLAR · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TRUSELTIQ · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vanflyta · Venclexta · Vitrakvi · XALKORI · XPOVIO · XTANDI · Xermelo · ZEJULA · ZENPEP · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
121
Per 100K population
9.5
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nadeau is a mixed practice specialist, with above-average Medicare volume (top 7% in MI), with low-engagement industry engagement in the top 17% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nadeau experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Nadeau performed 26,520 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nadeau receive payments from pharmaceutical companies?
Yes. Dr. Nadeau received a total of $10,701 from 88 companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nadeau's costs compare to other hematology & oncology specialists in Royal Oak?
Dr. Nadeau's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nadeau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Royal Oak
Browse hematology & oncology specialists in Royal Oak ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology